Elucidating the pre- and post-nuclear intracellular processing of 1,4-dihydropyridine based gene delivery carriers

Zanna Hyvönen1, Vesa Hämäläinen, Marika Ruponen

  • 1School of Pharmacy, Department of Health Sciences, University of Eastern Finland, PO Box 1627 FIN-70211 Kuopio, Finland. zanna.hyvonen@uef.fi

Insights

Non-viral gene delivery using 1,4-dihydropyridine (1,4-DHP) complexes faces challenges. This study reveals that successful transgene expression depends equally on pre- and post-nuclear intracellular processes, not just plasmid uptake.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Low transfection efficacy of non-viral gene delivery systems hinders therapeutic applications.
  • Understanding the structure/activity relationship of 1,4-dihydropyridine (1,4-DHP) derivatives for DNA delivery is crucial.
  • Intracellular processing significantly impacts transgene expression efficiency.

Purpose of the Study:

  • To investigate the intracellular processing of 1,4-DHP complexes in retinal pigment epithelial cells.
  • To elucidate the correlation between cellular uptake, nuclear plasmid amount, mRNA expression, and transgene expression.
  • To identify critical steps influencing gene expression following non-viral gene delivery.

Main Methods:

  • Utilized three structurally related 1,4-DHP derivatives for complex formation with DNA.
  • Quantified pre- and post-nuclear processing at nuclear, mRNA, and transgene expression levels in ARPE-19 cells.
  • Assessed cellular uptake mechanisms, endosomal escape, and intracellular processing stages.

Main Results:

  • 1,4-DHP complexes are internalized primarily via endocytosis and can destabilize endosomal membranes.
  • No correlation found between plasmid uptake and nuclear plasmid quantity, or between nuclear plasmid amount and mRNA expression.
  • mRNA expression did not consistently lead to functional protein production, indicating post-translational modification interference.

Conclusions:

  • Successful gene delivery requires efficient pre-nuclear (uptake, endosomal escape) and post-nuclear (nuclear processing, translation) events.
  • The structure/activity relationship of 1,4-DHP derivatives impacts intracellular processing and gene expression outcomes.
  • Optimizing non-viral gene delivery necessitates addressing multiple intracellular barriers beyond mere cellular uptake.